PRLD - SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Prelude Therapeutics Incorporated (NASDAQ: PRLD) and Encourages Investors to Contact the Firm | Benzinga
PHILADELPHIA, Nov. 11, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Prelude Therapeutics Incorporated (NASDAQ:PRLD) ("Prelude") on behalf of the company's investors.
Since April 2023, shares of Prelude's common stock have declined in value from a trading price of over $6.00 per share to a current trading price of approximately $3.00 per share, a cumulative decline of over 50% in value.
The ...
PRLD) and Encourages Investors to Contact the Firm>Full story available on Benzinga.com